Drug class in one race
Interferon beta receptor (type I IFN signaling) drugs for Multiple Sclerosis
3 tracked Interferon beta receptor (type I IFN signaling) drugs in the Multiple Sclerosis race. The class explanation lives on the Interferon beta receptor (type I IFN signaling) page; the full indication pipeline across every mechanism is on the Multiple Sclerosis page.
3 approved / phase 4
Head-to-head evidence: Interferon beta-1b vs Rebif (interferon beta 1a) · Interferon beta-1b vs peginterferon beta-1a · peginterferon beta-1a vs Rebif (interferon beta 1a)